EPA v. JANSSEN PHARMACEUTICAL, INC

Case summary

During an October 13, 2005, import inspection, EPA found that Janssen Pharmaceutical, Inc. (Janssen), had shipped to the U.S. a pesticide in violation of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). On October 15, 2005, the EPA inspected a similar product again imported by Janssen and found that it too was in violation of FIFRA. The October 15 inspection showed that the product label bore three EPA pesticide producing establishment numbers with no indication of which number represented the establishment that last produced the product, and was missing the required precautionary statement, �Have the product container or label with you when calling a poison control center or doctor, or going for treatment.� Furthermore, the NOA submitted by Janssen�s import broker, BDP International, Inc., contained false and inaccurate information when compared to the actual product being imported. To gain control over the illegal shipment, the EPA issued a Stop Sale Use or Removal Order on October 20, 2005, which outlined several conditions that Janssen had to meet in order to further sell and distribute the product. This penalty action is in follow up to the October 20, 2005, Order. Janssen was very cooperative during the Stop Sale Order and the settlement negotiations.

Defendants (1)

• WILLIAM GOODWINNamed in complaintNamed in settlement

Facilities (1)

• JANSSEN PHARMACUETICAL INC

  2580 S 156TH ST, BLDG A, SEATTLE, WA, 98158

  Registry ID: 110012560442

Statutes cited

• FIFRA 12A1E — Adulterated/Misbranded

Enforcement conclusions (1)

• JANSSEN PHARMACEUTICAL, INCentered 2006-04-12

  Primary law: FIFRA

  Federal penalty: $4,680

Timeline (4 milestones)

• 2006-03-28Enforcement Action Data Entered
• 2006-04-12Complaint Filed/Proposed Order
• 2006-04-12Final Order Issued
• 2007-04-16Enforcement Action Closed